Selective estrogen receptor modulators (SERMs): Mechanisms of anticarcinogenesis and drug resistance

2005/08/04 by Joan S. Lewis, V. Craig Jordan · 1 citation
Biochemistry, Genetics and Molecular Biology · Medicine · #Cytokine Signaling Pathways and Interactions #Estrogen and related hormone effects #Inflammatory mediators and NSAID effects

paper · doi:10.1016/j.mrfmmm.2005.02.028

openalex publication_date 2005/08/04 · crossref created 2005/08/04 · crossref issued 2005/12/01 · crossref published 2005/12/01 · crossref published-print 2005/12/01 · openalex created_date 2025/10/10 · crossref deposited 2025/12/02 · crossref indexed 2026/04/30 · openalex updated_date 2026/08/01

Citations

• Linkage of Rapid Estrogen Action to MAPK Activation by ERα-Shc Association and Shc Pathway Activation
• Genotoxic metabolites of estradiol in breast: potential mechanism of estradiol induced carcinogenesis
• Molecular Determinants for the Tissue Specificity of SERMs
• Structural Insights into the Mode of Action of a Pure Antiestrogen
• AIB1, a Steroid Receptor Coactivator Amplified in Breast and Ovarian Cancer
• Comparison of the Ligand Binding Specificity and Transcript Tissue Distribution of Estrogen Receptors α and β
• The crystal structure of the estrogen receptor DNA-binding domain bound to DNA: How receptors discriminate between their response elements
• Antiestrogens and Selective Estrogen Receptor Modulators as Multifunctional Medicines. 2. Clinical Considerations and New Agents

Cited by

• Selective estrogen receptor modulator [wikipedia]